Red List

GPCRStructure Therapeutics Inc.

Healthcare · Biotechnology · mid-cap ($2.9B)
-63.0%
from rolling 252-day high of $94.90 set 2025-12-08 · 284d ago
Current
$35.00
Decline depth
-63.0%
Decline σ
8.1σ
TFC
0/5 bearish

Where it stands

On the Red List.

Down 63.0% from its rolling 252-day high, 284 days after the high.

Snapshot . Price structure, not a judgment about the business.

What changed

Since the previous observation.

Tier and recovery signal are unchanged between these two observations.

Comparing with . This compares classification, not price returns.

See the recorded timeline →

Why it is flagged

GPCR qualifies for the Red List on decline depth.

Down 63.0% from its rolling 252-day high, 284 days after the high. The most severe triggered rule determines the tier.

Inspect the three classification measures
Decline depth
-63.0%
From rolling 252-day high of $94.90, 284d ago. Past the 40% Red List threshold.
Time-frame continuity
0/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
8.1σ
Drop over the last 20 bars in units of daily volatility (4.04%/day). Past the ≥8σ Red List threshold — an extreme move.

Price history

The price path behind the snapshot.

Daily prices with the rolling-high reference. When a recorded classification event falls on a displayed trading date, it is marked on the chart.

Rolling 252-day high Gold dots: recorded classification events (see timeline) Up day Down day 90 daily bars from Alpaca · through

The recorded history

A timeline of observations.

First observed 2026-09-09. These are scan observations, not exact transition times or the start of a decline. Missing scan dates are not filled in.

  1. First observed: Red List

Absence from a captured list does not establish recovery. Historical tiers reflect the rules and data recorded at that time.

Technical interpretation and signal details

The structural read

What price action says about GPCR.

GPCR qualifies for the Red List on decline depth — down -63.0% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.

Cross-confirmation: decline sigma also reads 8.1σ over 20 bars.

Questions about GPCR

What people ask.

Why is GPCR on Broken Stocks?

GPCR qualifies for the Red List on decline depth. It is down -63.0% from its rolling 252-day high of $94.90, set on 2025-12-08 — 284d ago.

Is GPCR a falling knife?

Not by the strict technical definition. GPCR is down -63.0% from its 52-week high, but that high was set 284d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. GPCR is still on the Red List for decline depth, but the freshness component of a falling knife is missing.

Is GPCR a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is GPCR trading inside its 52-week range?

At $35.00, GPCR sits 20.0% of the way from its 52-week low ($20.04) to its 52-week high ($94.90). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has GPCR been declining?

The current 63.0% decline accrued over 284d, which annualizes to roughly -81.0% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does GPCR compare to its sector?

There are 344 other Healthcare tickers on Broken Stocks: 198 Red, 87 Amber, 59 Watch, with 168 showing recovering structural signals. Median sector decline is -36.5% — GPCR's decline is deeper than the sector median.